Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Enzymatic Therapy Acquired - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Enzymatic Therapy Acquired

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Springville, UT-based Nature’s Way Holding Company, a subsidiary of Germany-based Dr. Willmar Schwabe Pharmaceuticals, has reached an agreement with North Castle Partners, LLC to acquire all outstanding shares of Enzymatic Therapy, Green Bay, WI, pending approval of other shareholders. Schwabe Pharmaceuticals comprises six companies in Germany and more than 20 subsidiaries and joint ventures around the world. The initial focus of the deal will be to advance product development and bring more natural health solutions to market. “We believe the complementary product portfolios and marketing know-how of Enzymatic Therapy and Nature’s Way will significantly strengthen our presence in the U.S. market, which is one of Schwabe’s strategic key markets for future growth,” said Dr. Dirk Reischig, chairman and CEO of Schwabe Pharmaceuticals.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters